---
title: "Montai Therapeutics Doses First Participants in Phase 1 Clinical Trial of MTAI-1025, a Novel Oral NRF2 Agonist for Ulcerative Colitis | Montai"
author: "Montai"
date: "2026-10-01T12:00:00+00:00"
language: "en-US"
canonical_url: "https://www.montai.com/montai-therapeutics-doses-first-participants-nrf2/"
source_url: "https://www.montai.com/montai-therapeutics-doses-first-participants-nrf2/"
content_type: "text/markdown"
---

News



News